You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, June 2021
|
| DOI | 10.1136/jitc-2021-002435 |
| Pubmed ID | |
| Authors |
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff |
X Demographics
The data shown below were collected from the profiles of 93 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 31 | 33% |
| Japan | 5 | 5% |
| Italy | 4 | 4% |
| Spain | 3 | 3% |
| Germany | 3 | 3% |
| Canada | 3 | 3% |
| United Kingdom | 2 | 2% |
| Singapore | 1 | 1% |
| Switzerland | 1 | 1% |
| Other | 4 | 4% |
| Unknown | 36 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 57 | 61% |
| Practitioners (doctors, other healthcare professionals) | 17 | 18% |
| Scientists | 14 | 15% |
| Science communicators (journalists, bloggers, editors) | 5 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 307 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 30 | 10% |
| Other | 29 | 9% |
| Researcher | 24 | 8% |
| Student > Master | 19 | 6% |
| Student > Postgraduate | 16 | 5% |
| Other | 49 | 16% |
| Unknown | 140 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 32% |
| Biochemistry, Genetics and Molecular Biology | 16 | 5% |
| Nursing and Health Professions | 9 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 2% |
| Immunology and Microbiology | 6 | 2% |
| Other | 29 | 9% |
| Unknown | 142 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2023.
All research outputs
#251,421
of 25,726,194 outputs
Outputs from Journal for Immunotherapy of Cancer
#45
of 3,495 outputs
Outputs of similar age
#7,090
of 457,219 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 180 outputs
Altmetric has tracked 25,726,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,495 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.